Intellectual Property India Publishes Patent Application for 'Therapeutic Combination And Use Thereof' Filed by Akeso Biopharma, Inc.; and Akeso Pharmaceuticals, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517027882 A) filed by Akeso Biopharma, Inc.; and Akeso Pharmaceuticals, Inc., Guangdong, China, on March 25, for 'therapeutic combination and use thereof.'

Inventor(s) include Wang, Zhongmin; Li, Baiyong; and Xia, Yu.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are a pharmaceutical composition and use thereof. The pharmaceutical composition comprises an anti-CTLA4 and anti-PD-1 bispecific antibody and an anti-PD-1 and anti-VEGFA bispecific antibody. The pharmaceutical composition of the present invention can treat or prevent ...